Preview Mode Links will not work in preview mode

This Week in Cardiology

Mar 12, 2021

COVID-19, heart failure classifications, DOAC after bioprosthetic valves, and Medicare spending in the pandemic year Are the topics discussed by John Mandrola, MD, in this week’s podcast.

I. COVID-19 Vaccination in Israel

COVID-19 Vaccination Linked to Less Mechanical Ventilation

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

II. Heart Failure Classification

Heart Failure Redefined With New Classifications, Staging

Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure

III. DOACs In Bioprosthetic Valves --

DOACs Offered After Heart Valve Surgery Despite Absence of Data

Off-label Use of Direct Oral Anticoagulants in Patients Receiving Surgical Mechanical and Bioprosthetic Heart Valves

Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation:

Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document....

IV. Pandemic Slices Medicare Physician Spending in First Half of 2020: AMA

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact